Accessibility Menu

Pomdoctor(NASDAQ) POM

Market Cap$6.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-99%
5 YearN/A
1 YearN/A
1 Month+72%
$0.98
+3.70%
+0.04Today
Pomdoctor last closing stock price
MetricPriceDate
Last closeUSD 0.952026-08-31
Pomdoctor stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.11%USD 0.972026-08-24
1 month+71.79%USD 0.552026-07-31
3 month-50.28%USD 1.902026-06-02
Year to date-82.2%USD 5.312025-12-31
Since inception-98.7%USD 72.542025-10-08

Pomdoctor Financials at a Glance

Market Cap

$6.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-5.53 (Low)

Price

$0.98

Volume

14,231.5

Open

$1.00

Previous Close

$0.98

Daily Range

$0.93 - $1.00

52-Week Range

$0.50 - $115.74

Estimated Earnings Date

Aug 13, 2026

POM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pomdoctor

POMDOCTOR Ltd is a healthcare company focused on providing an e-commerce platform for the direct sale of pharmaceutical products. The company is developing an online healthcare services platform aimed at managing long-term illnesses, particularly in the Chinese market.

Products and Services
  • E-commerce platform for pharmaceutical products
  • Online healthcare services for chronic disease management
  • Virtual hospital model connecting patients and medical professionals
Growth Outlook
  • Expansion into the Chinese market presents significant growth opportunities
  • Increasing demand for online healthcare services drives potential revenue growth
  • Focus on chronic disease care aligns with market trends in healthcare
Financial Highlights
  • Recent quarterly cash and cash equivalents reached CNY 9,580,367
  • Total assets increased to CNY 107,557,426 in the latest quarter
  • Current liabilities totaled CNY 218,168,136, indicating financial obligations
POMDOCTOR Ltd operates within the medical and pharmaceutical industry, leveraging technology to enhance healthcare delivery. The company's innovative approach to chronic disease management and pharmaceutical distribution positions it well for future growth. The focus on the Chinese market, combined with the increasing demand for digital healthcare solutions, suggests a promising trajectory for the company. Recent financial data indicates a solid asset base, although attention to liabilities is essential for sustainable growth. Overall, POMDOCTOR Ltd represents an intriguing opportunity within the evolving healthcare landscape.
AI Generated • Aug 21, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

165

CEO

Zhen Yang Shi, EMBA

Website

www.7lk.com

Headquarters

Guangzhou, GD 510000, CN

POM Financials

Key Financial Metrics (TTM)

Gross Margin

13.07%

Operating Margin

-29.10%

Net Income Margin

-53.16%

Return on Equity

15.65%

Return on Capital

-12014.22%

Return on Assets

-197.64%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.77M

Volume

14.23K

Avg. Volume

84.87K

Financials (TTM)

Gross Profit

CN¥52.28M

Operating Income

-CN¥116.37M

EBITDA

-CN¥117.90M

Operating Cash Flow

-CN¥148.48M

Capital Expenditure

-CN¥1.01M

Free Cash Flow

-CN¥149.49M

Cash & ST Invst.

CN¥9.58M

Total Debt

CN¥454.94M

Pomdoctor Performance Analysis

Pomdoctor annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 36,416,2669.0%
20232023-12-31CNY 43,027,76918.2%
20242024-12-31CNY 47,598,52810.6%
20252025-12-31CNY 55,633,00516.9%
Pomdoctor sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q42025-12-31N/A
Pomdoctor annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY -2.83-36.2%
20232023-12-31CNY -3.1210.1%
20242024-12-31CNY -3.03-2.9%
20252025-12-31CNY -9.16202.7%
Pomdoctor sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$6.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIRSAirSculpt Technologies, Inc.
$2.43-3.77%
AVXLAnavex Life Sciences Corp.
$2.87+2.50%
OFIXOrthofix Medical Inc.
$9.43+0.43%
PACBPacific Biosciences of California, Inc.
$1.28-5.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$14.06+0.06%
NVDANvidia
$217.44-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.33-0.06%
INTCIntel
$88.97-0.01%

Questions About POM

What is the current price of Pomdoctor?

Pomdoctor is trading at $0.98 per share.

What is the 52-week range for Pomdoctor?

Over the past 52 weeks, Pomdoctor has traded between $0.50 and $115.74.

How much debt does Pomdoctor have?

As of the most recent reporting period, Pomdoctor reported total debt of CN¥65.10M.

How much cash does Pomdoctor have on hand?

Pomdoctor reported CN¥1.37M in cash and cash equivalents in its most recent financial results.

What is Pomdoctor’s dividend yield?

Pomdoctor does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services